Synergism in the pathogenesis of EAE induced by an MBP-specific T-cell line and monoclonal antibodies to galactocerebroside or a myelin oligodendroglial glycoprotein.
Fierz
W
W
Section of Clinical Immunology, University Hospital, Zürich, Switzerland.
Heininger
K
K
Schaefer
B
B
Toyka
K V
KV
Linington
C
C
Lassmann
H
H
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002460:Cell Line; D002554:Cerebrosides / Q000276:immunology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000473:pathology; D005699:Galactosylceramides / Q000276:immunology*; D006023:Glycoproteins / Q000276:immunology; D004676:Myelin Basic Protein / Q000276:immunology*; D009457:Neuroglia / Q000276:immunology*; D009836:Oligodendroglia / Q000276:immunology*; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D002554:Cerebrosides; D005699:Galactosylceramides; D006023:Glycoproteins; D004676:Myelin Basic Protein; C002454:galactocerebroside